Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease
Hong Wang, Kaushik Dey, Ping‐Chung Chen, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
Theophania Ashleigh, Russell H. Swerdlow, M. Flint Beal
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 333-342
Closed Access | Times Cited: 243
Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bing Bai, David Vanderwall, Yuxin Li, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 167
The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome
Eleanor Drummond, Tomas Kavanagh, Geoffrey Pires, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 105
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Eric B. Dammer, Lingyan Ping, Duc M. Duong, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 105
Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function
Chia‐Chen Liu, Jing Zhao, Yuan Fu, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 8, pp. 1020-1033
Open Access | Times Cited: 101
Compilation of reported protein changes in the brain in Alzheimer’s disease
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 78
Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling
Qing‐Qing Tao, Xue Cai, Yan‐Yan Xue, et al.
The Innovation (2024) Vol. 5, Iss. 1, pp. 100544-100544
Open Access | Times Cited: 24
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment
Eric B. Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 17
CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity
Lingyun Long, Jun Wei, Seon Ah Lim, et al.
Nature (2021) Vol. 600, Iss. 7888, pp. 308-313
Open Access | Times Cited: 81
Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications
Loı̈c Dayon, Ornella Cominetti, Michael Affolter
Expert Review of Proteomics (2022) Vol. 19, Iss. 2, pp. 131-151
Closed Access | Times Cited: 62
Protein lifetimes in aged brains reveal a proteostatic adaptation linking physiological aging to neurodegeneration
Verena Kluever, Belisa Russo, Sunit Mandad, et al.
Science Advances (2022) Vol. 8, Iss. 20
Open Access | Times Cited: 44
CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
Emma L. van der Ende, Sjors G. J. G. In ‘t Veld, Iris Hanskamp, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4495-4507
Open Access | Times Cited: 31
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
Daniel J. Panyard, Justin McKetney, Yuetiva Deming, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5447-5470
Open Access | Times Cited: 26
Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
Ying Han, Daozhou Liu, Ying Cheng, et al.
Redox Biology (2023) Vol. 63, pp. 102734-102734
Open Access | Times Cited: 23
Focusing on mitochondria in the brain: from biology to therapeutics
Nanshan Song, Shuyuan Mei, Xiang-Xu Wang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid
Aleksandra Wojtas, Eric B. Dammer, Qi Guo, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4043-4065
Open Access | Times Cited: 13
Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
Fangjia Yang, Paula Beltran-Lobo, Katherine Sung, et al.
Science Advances (2024) Vol. 10, Iss. 12
Open Access | Times Cited: 12
Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer’s disease
Yona Levites, Eric B. Dammer, Yong Ran, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101669-101669
Open Access | Times Cited: 12
Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease
Roberto Collu, Zheng Yin, Elisa Giunti, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 10
Wireless radiation and health: making the case for proteomics research of individual sensitivity
Dariusz Leszczyński
Frontiers in Public Health (2025) Vol. 12
Open Access | Times Cited: 1
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
Banglian Hu, Shengshun Duan, Ziwei Wang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 54
Platelet biomarkers for a descending cognitive function: A proteomic approach
Haitao Yu, Yanchao Liu, Benrong He, et al.
Aging Cell (2021) Vol. 20, Iss. 5
Open Access | Times Cited: 43
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective
Morteza Abyadeh, Vivek Gupta, Nitin Chitranshi, et al.
Expert Review of Proteomics (2021) Vol. 18, Iss. 4, pp. 295-304
Closed Access | Times Cited: 42
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top